Literature DB >> 26251046

Possible Alternatives to Diagnosis-Based Denominators for Addiction Treatment Quality Measures.

Alex H S Harris1, Anna D Rubinsky2, Katherine J Hoggatt3.   

Abstract

Consumers of healthcare quality measures are often unaware of how measured performance may be driven by diagnosing practices rather than the provision of high quality care. Reliance on quality metrics that depend on documented diagnoses can therefore subvert comparisons between clinicians, facilities or systems. In this study, three versions of an alcohol use disorder (AUD) treatment quality measure were calculated: method 1--the usual denominator including all diagnosed patients; method 2--a "population-based" denominator including the entire facility census; and method 3-an epidemiologically-derived denominator comprising the expected prevalence of AUD based on case-mix characteristics and geographic region. Performance rankings under the three specifications were calculated. Changes in percentile rank of up to 30-45% were observed between methods. Therefore, much of the observed between-facility differences on diagnosis-based quality measures may reflect variation in the propensity to diagnose rather than real differences in performance. Stakeholders must decide which of the validity threats produced by these different methods is least worrisome. Published by Elsevier Inc.

Entities:  

Keywords:  Methodology; Quality comparisons; Quality measurement; Validity

Mesh:

Year:  2015        PMID: 26251046     DOI: 10.1016/j.jsat.2015.06.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  8 in total

1.  Quality of care measures for the management of unhealthy alcohol use.

Authors:  Kimberly A Hepner; Katherine E Watkins; Carrie M Farmer; Lisa Rubenstein; Eric R Pedersen; Harold Alan Pincus
Journal:  J Subst Abuse Treat       Date:  2017-01-26

2.  Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder.

Authors:  Brian Shiner; Christine Leonard Westgate; Nancy C Bernardy; Paula P Schnurr; Bradley V Watts
Journal:  J Dual Diagn       Date:  2017-05-08

3.  Alcohol-related and mental health care for patients with unhealthy alcohol use and posttraumatic stress disorder in a National Veterans Affairs cohort.

Authors:  Jessica A Chen; Mandy D Owens; Kendall C Browne; Emily C Williams
Journal:  J Subst Abuse Treat       Date:  2017-11-22

4.  Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration.

Authors:  Emily C Williams; Olivia V Fletcher; Madeline C Frost; Alex H S Harris; Donna L Washington; Katherine J Hoggatt
Journal:  JAMA Netw Open       Date:  2022-06-01

5.  Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.

Authors:  Kelsey C Priest; Travis I Lovejoy; Honora Englander; Sarah Shull; Dennis McCarty
Journal:  J Gen Intern Med       Date:  2020-04-14       Impact factor: 5.128

6.  Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science.

Authors:  Andrea K Finlay; Ingrid A Binswanger; Christine Timko; David Smelson; Matthew A Stimmel; Mengfei Yu; Tom Bowe; Alex H S Harris
Journal:  J Subst Abuse Treat       Date:  2018-10-02

7.  Are Improvements in Measured Performance Driven by Better Treatment or "Denominator Management"?

Authors:  Alex H S Harris; Cheng Chen; Anna D Rubinsky; Katherine J Hoggatt; Matthew Neuman; Megan E Vanneman
Journal:  J Gen Intern Med       Date:  2016-04       Impact factor: 5.128

8.  Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care.

Authors:  Alex H S Harris; Constance M Weisner; Mady Chalk; Victor Capoccia; Cheng Chen; Cindy Parks Thomas
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.